Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management
Human coronavirus-associated myocarditis is known, and a number of coronavirus disease
19 (COVID-19)–related myocarditis cases have been reported. The pathophysiology of …
19 (COVID-19)–related myocarditis cases have been reported. The pathophysiology of …
Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
S Natoli, V Oliveira, P Calabresi… - European journal of …, 2020 - Wiley Online Library
The current coronavirus disease (COVID‐19) outbreak, caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has raised the possibility of potential …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has raised the possibility of potential …
[HTML][HTML] Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
C Wu, Y Liu, Y Yang, P Zhang, W Zhong… - … Pharmaceutica Sinica B, 2020 - Elsevier
SARS-CoV-2 has caused tens of thousands of infections and more than one thousand
deaths. There are currently no registered therapies for treating coronavirus infections …
deaths. There are currently no registered therapies for treating coronavirus infections …
Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment
Summary COVID-19, caused by SARS-CoV-2, is a virulent pneumonia, with> 4,000,000
confirmed cases worldwide and> 290,000 deaths as of May 15, 2020. It is critical that …
confirmed cases worldwide and> 290,000 deaths as of May 15, 2020. It is critical that …
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice
Pathogenic coronaviruses are a major threat to global public health, as exemplified by
severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory …
severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory …
Histopathological observations in COVID-19: a systematic review
Background Coronavirus disease-2019 (COVID-19) has caused a great global threat to
public health. The World Health Organization (WHO) has declared COVID-19 disease as a …
public health. The World Health Organization (WHO) has declared COVID-19 disease as a …
[HTML][HTML] Cardiovascular complications of COVID-19
F Farshidfar, N Koleini, H Ardehali - JCI insight, 2021 - ncbi.nlm.nih.gov
The emergence of the novel SARS coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …
Animal and translational models of SARS-CoV-2 infection and COVID-19
COVID-19 is causing a major once-in-a-century global pandemic. The scientific and clinical
community is in a race to define and develop effective preventions and treatments. The …
community is in a race to define and develop effective preventions and treatments. The …
2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness
R Ralph, J Lew, T Zeng, M Francis, B Xue… - The Journal of Infection …, 2020 - jidc.org
On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical
pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first …
pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first …
Pulmonary and extra-pulmonary clinical manifestations of COVID-19
KD Johnson, C Harris, JK Cain, C Hummer… - Frontiers in …, 2020 - frontiersin.org
The severe acute respiratory syndrome coronavirus− 2 (SARS-CoV-2) has been recently
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …
identified as the culprit of the highly infectious, outbreak named coronavirus disease 2019 …